News

Fierce Biotech5d
Eli Lilly pens Creyon Bio AI oligonucleotide pact with $1B in biobucks on the table
Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed ...
RIPR: The Public's Radio12d
Eli Lilly sues companies selling alternative versions of its weight loss drug
An Eli Lilly & Co. Zepbound injection pen. (Bloomberg/Bloomberg via Getty Images | Bloomberg) Eli Lilly, the drugmaker behind ...
MarketBeat on MSN11d
Eli Lilly Nails Oral GLP-1 Trial-Here's What It Means for LLY
CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), is back in the green ...
Exclusive-WHO set to back use of weight-loss drugs for adults globally, raises cost issue
The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...